H. Kiener et al., INCREASED LEVELS OF CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 IN PATIENTS WITH SYSTEMIC-SCLEROSIS, Clinical and experimental rheumatology, 12(5), 1994, pp. 483-487
Objective: To determine the value of the circulating intercellular adh
esion molecule (cICAM-1) as a marker for the inflammatory and fibrotic
yi processes in systemic sclerosis (SSc). Methods: We determined seru
m levels of cICAM-1 and of the soluble interleukin-2 receptor (sIL-2R)
by an enzyme-linked immunosorbent assay in 33 patients with SSc. Thes
e valises were compared to the concentrations of acute phase reactants
and to the extent of skin involvement in diffuse and limited sclerode
rma. Results: cICAM-1 was elevated in patients with diffuse SSc (498 /- 134 ng/ml) as compared with 82 healthy controls (312 +/- 71 ng/ml)
(mean +/- SD, p +/- 0.0001). The elevation of cICAM-1 did not correlat
e with the duration of disease, the pattern of organ manifestations or
rite type of treatment. While the concentrations of acute phase prote
ins were not elevated in SSc, a significant correlation between increa
sed serum sIL-2R and cICAM-1 was observed. Conclusion: Increased level
s of cICAM-1 indicate an activation of immune processes in SSc. The cl
inical value of the cICAM-1 determination in SSc can only be judged in
longitudinal studies.